ORGO - Organogenesis Holdings Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
492.78M
Enterprise Value 3
520.33M
Trailing P/E
N/A
Forward P/E 1
-10.56
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.97
Price/Book (mrq)
35.19
Enterprise Value/Revenue 3
2.08
Enterprise Value/EBITDA 6
-25.49

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-68.87%
S&P500 52-Week Change 322.86%
52 Week High 315.9960
52 Week Low 33.5600
50-Day Moving Average 34.9015
200-Day Moving Average 35.7019

Share Statistics

Avg Vol (3 month) 3151.3k
Avg Vol (10 day) 362.54k
Shares Outstanding 5103.74M
Float 9.33M
% Held by Insiders 171.86%
% Held by Institutions 128.42%
Shares Short (Dec 30, 2019) 476.34k
Short Ratio (Dec 30, 2019) 40.47
Short % of Float (Dec 30, 2019) 40.27%
Short % of Shares Outstanding (Dec 30, 2019) 40.07%
Shares Short (prior month Nov 28, 2019) 482.86k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -18.13%
Operating Margin (ttm)-11.65%

Management Effectiveness

Return on Assets (ttm)-10.69%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)249.94M
Revenue Per Share (ttm)2.85
Quarterly Revenue Growth (yoy)26.60%
Gross Profit (ttm)124.64M
EBITDA -20.42M
Net Income Avi to Common (ttm)-45.96M
Diluted EPS (ttm)-0.5240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.97M
Total Cash Per Share (mrq)0.24
Total Debt (mrq)100.85M
Total Debt/Equity (mrq)787.38
Current Ratio (mrq)1.42
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-44.64M
Levered Free Cash Flow (ttm)-27.83M